Douglas Matthew Brown - 01 Apr 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Strategy Officer
Signature
/s/ Halley E. Gilbert, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
01 Apr 2022
Net transactions value
$0
Form type
4
Filing time
04 Apr 2022, 19:07:12 UTC
Previous filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +82,305 +108% $0.000000 158,684 01 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 45,017 01 Apr 2022 Common Stock 45,017 $28.33 Direct F2
holding NEO Stock Option (Right to Buy) 26,378 01 Apr 2022 Common Stock 26,378 $53.17 Direct F3
holding NEO Stock Option (Right to Buy) 85,519 01 Apr 2022 Common Stock 85,519 $21.41 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 1, 2022, Mr. Brown was granted 82,305 restricted stock awards. These awards vest on the first anniversary date of the grant date.
F2 On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F4 On March 1, 2022, Mr. Brown was granted 85,519 stock options. These options vest ratably over the first four anniversary dates of the grant date.